Perspective Therapeutics Correlations

CATX Stock   2.52  0.03  1.20%   
The current 90-days correlation between Perspective Therapeutics and Sight Sciences is 0.14 (i.e., Average diversification). The correlation of Perspective Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Perspective Therapeutics Correlation With Market

Very weak diversification

The correlation between Perspective Therapeutics and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Perspective Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Perspective Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Moving together with Perspective Stock

  0.81HOLX HologicPairCorr
  0.71INFU InfuSystems HoldingsPairCorr
  0.66SSKN STRATA Skin Sciences Earnings Call TodayPairCorr
  0.74ELEV Elevation OncologyPairCorr
  0.8GPCR Structure TherapeuticsPairCorr
  0.79ZVSA ZyVersa TherapeuticsPairCorr
  0.66IMMX Immix BiopharmaPairCorr
  0.77IMRX Immuneering CorpPairCorr
  0.65KRON Kronos BioPairCorr
  0.85PYXS Pyxis OncologyPairCorr
  0.62RAIN Rain Enhancement TecPairCorr
  0.79SCLX Scilex HoldingPairCorr
  0.76ASMB Assembly Biosciences Earnings Call TomorrowPairCorr

Moving against Perspective Stock

  0.81OCX OncoCyte CorpPairCorr
  0.73LUCD Lucid DiagnosticsPairCorr
  0.64GOSS Gossamer BioPairCorr
  0.62MNDR Mobile health NetworkPairCorr
  0.48PAVM PAVmed IncPairCorr
  0.48NVCT Nuvectis PharmaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ELMDCVRX
ELMDOFIX
CVRXOFIX
SRDXSGHT
NPCEOFIX
CVRXNPCE
  
High negative correlations   
SGHTKIDS
ELMDPAVM
SRDXKIDS
PAVMSGHT
SRDXPAVM
HYPRSGHT

Risk-Adjusted Indicators

There is a big difference between Perspective Stock performing well and Perspective Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Perspective Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KIDS  1.90  0.23  0.11  0.22  1.98 
 3.54 
 15.28 
OFIX  1.23 (0.08) 0.00 (0.13) 0.00 
 2.18 
 6.60 
SGHT  3.39 (0.12) 0.00 (0.14) 0.00 
 7.19 
 24.66 
NPCE  3.17  0.20  0.06  2.38  3.79 
 5.89 
 17.98 
CVRX  3.08  0.05  0.01 (0.01) 3.82 
 5.58 
 14.59 
PAVM  3.91  0.35  0.08  0.19  3.71 
 12.07 
 27.49 
OSA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HYPR  5.23  0.07  0.01 (0.12) 8.05 
 11.36 
 68.04 
ELMD  2.31 (0.15) 0.00 (0.18) 0.00 
 3.90 
 21.31 
SRDX  1.51 (0.38) 0.00 (0.67) 0.00 
 2.15 
 10.84 

Perspective Therapeutics Corporate Management

Annie ChengVice RelationsProfile
Andrew BrightExecutive BrachytherapyProfile
Michael SchultzChief OfficerProfile
Steve KeefeSenior DevelopmentProfile
PGradDip BAChief OfficerProfile
Jonathan HuntChief OfficerProfile